Tectonic Therapeutic, Inc.

TECX

Tectonic Therapeutic, Inc.

TECX

Insider Sentiment (TTM):

Last Purchase:2026-02-11Last Sale:2026-05-04Shares Purchased (TTM):8,500Shares Sold (TTM):19,977

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,267,867Shares Outstanding:18,769,004Institutional Ownership Pct.:70.69%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	227	237	254	268	287	306	141	159	185	19	29	6
Prepaid Expense And Other Assets Current	4	3	3	4	3	3	6	4	2	1	2	3
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	-	-	-	-	-	-	-	-	-	0
Restricted Cash Current	0	0	1	1	-	-	0	-	-	0	0	0
Assets Current	231	240	257	273	291	310	147	163	187	92	31	109
Property Plant And Equipment Net	1	1	1	1	2	2	2	3	3	-	3	0
Finance Lease Right Of Use Asset	-	0	0	1	1	1	1	1	2	-	1	-
Operating Lease Right Of Use Asset	4	4	1	1	1	2	2	2	1	0	3	1
Deferred Costs	-	-	-	-	-	-	0	0	0	-	1	-
Restricted Cash Noncurrent	0	0	0	0	1	1	1	1	1	0	1	0
Other Assets Noncurrent	1	1	1	1	0	0	0	0	0	-	0	0
Assets	237	247	261	277	295	315	153	169	194	92	39	111
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	3	1	1	3	6	1	3	4	0	0	1
Accrued Liabilities Current	7	9	7	7	7	5	8	13	20	3	8	5
Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	0	0
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	-	0	-
Operating Lease Liability Current	1	1	1	1	1	2	2	1	1	0	1	2
Liabilities Current	10	13	10	9	11	14	12	17	26	4	41	8
Operating Lease Liability Noncurrent	3	3	0	0	0	0	0	1	1	-	2	0
Finance Lease Liability Noncurrent	-	0	0	0	0	0	0	1	1	-	1	-
Liabilities	13	16	10	9	12	14	12	18	28	4	43	8
Stockholders Equity
Preferred Stock Value	-	-	0	0	0	0	0	0	-	0	0	-
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	0	0	0	-	81	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	494	478	474	471	468	466	289	287	285	573	6	571
Accumulated Other Comprehensive Income Loss Net Of…	0	0	-0	-0	-0	0	0	-0	-0	-	-0	-
Retained Earnings Accumulated Deficit	-270	-248	-223	-204	-184	-164	-149	-136	-118	-484	-91	-468
Stockholders Equity	224	230	251	268	284	301	141	150	166	-100	-85	-80
Liabilities And Stockholders Equity	237	247	261	277	295	315	153	169	194	92	39	111
Preferred Stock Shares Authorized	-	-	10	10	10	10	10	10	-	10	0	-
Preferred Stock Par Or Stated Value Per Share	-	-	0	-	-	-	0	-	-	0	0	-
Preferred Stock Shares Issued	-	-	0	0	0	0	0	0	-	0	0	-
Preferred Stock Shares Outstanding	-	-	0	0	0	0	0	0	-	0	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	19	19	19	19	19	19	15	15	15	45	1	45
Shares Outstanding	19	19	19	19	19	19	15	15	15	45	1	45

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	16.00%	19.05%	13.03%	-	-	-	-	-	-	-	-	-
2025	2.33%	-5.80%	6.18%	16.51%	-30.66%	-21.76%	12.90%	9.95%	6.16%	24.86%	23.32%	16.55%
2024	18.40%	9.80%	17.60%	14.32%	105.60%	154.55%	7.79%	1.61%	13.38%	-27.14%	-10.91%	3.97%
2023	-	-	-	-0.64%	-1.28%	-2.56%	-13.42%	-8.72%	-8.72%	0.00%	-3.94%	16.54%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	22.29	18.51	26.63	29.15	25.60	22.92	12.65	9.39	7.21	26.17	0.76	14.44
Quick Ratio	21.90	18.28	26.32	28.70	25.30	22.67	12.17	9.19	7.12	25.87	0.70	14.06
Working Capital	220.73M	226.93M	247.69M	263.87M	279.49M	296.13M	135.25M	145.28M	161.39M	88.33M	-10.00M	101.61M
Leverage & Debt
Debt to Equity	0.06	0.07	0.04	0.04	0.04	0.05	0.09	0.12	0.17	-0.04	-0.51	-0.10
Interest Coverage TTM	-2,373.13	-1,824.29	-1,333.90	-1,033.91	-873.60	-659.84	-542.20	-266.93	-194.07	-177.03	-293.74	-937.13
Debt Ratio	0.06	0.07	0.04	0.03	0.04	0.04	0.08	0.11	0.14	0.04	1.10	0.07
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-4.52	-4.45	-4.05	-3.60	-3.53	-3.42	-6.83	-2.92	-12.09	-23.85	-33.76	-53.44
Free Cash Flow Per Share TTM	-3.54	-3.50	-3.29	-2.65	-2.75	-3.68	-6.98	-3.67	-14.68	-21.59	-32.29	-40.12
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	30.02%	42.30%	27.89%	56.63%	86.90%	77.31%	35.40%	-39.06%	-57.68%	-67.25%	-59.56%	-35.37%
EPS Growth (1Y)	28.07%	30.09%	-40.74%	23.29%	-70.79%	-85.66%	-79.77%	-94.54%	-82.19%	939.73%	1,294.43%	2,044.59%
Valuation Metrics
P/E TTM	-7.60	-6.95	-5.15	-4.36	-5.63	-5.18	-6.76	-10.39	-1.36	-0.64	-0.48	-0.35
P/B TTM	2.91	2.52	1.52	1.10	1.31	1.01	2.78	2.97	0.29	-0.21	-0.24	-0.31
Market Cap	651.98M	580.15M	382.21M	293.60M	371.17M	303.86M	391.99M	446.29M	48.09M	21.31M	20.70M	24.38M
Enterprise Value	424.43M	343.54M	127.73M	24.61M	83.84M	-2.21M	251.04M	287.60M	-136.51M	1.97M	-7.30M	17.46M
Calculated Values
Free Cash Flow TTM	-67.10M	-65.66M	-60.34M	-49.59M	-51.35M	-63.08M	-59.24M	-54.13M	-42.86M	-29.95M	-40.96M	-52.93M
Net Debt	-227.55M	-236.61M	-254.48M	-268.99M	-287.33M	-306.08M	-140.95M	-158.69M	-184.60M	-19.34M	-28.01M	-6.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-04Sale

Owner: Ruddy, Marcella K.

Title: Chief Medical Officer

Shares: 1,065

Price/Share: $30.00

Value: $31,950.00

Shares Owned: 67,682

Relationship: Officer

Ownership: Direct

2026-04-01Sale

Owner: Ruddy, Marcella K.

Title: Chief Medical Officer

Shares: 1,000

Price/Share: $31.05

Value: $31,050.00

Shares Owned: 68,747

Relationship: Officer

Ownership: Direct

2026-03-06Sale

Owner: Mcnamara, Peter

Title: Chief Scientific Officer

Shares: 6,262

Price/Share: $32.50

Value: $203,515.00

Shares Owned: 55,285

Relationship: Officer

Ownership: Direct

2026-03-06Sale

Owner: Ruddy, Marcella K.

Title: Chief Medical Officer

Shares: 10,000

Price/Share: $30.00

Value: $300,000.00

Shares Owned: 69,747

Relationship: Officer

Ownership: Direct

2026-03-04Sale

Owner: Mcnamara, Peter

Title: Chief Scientific Officer

Shares: 1,650

Price/Share: $25.00

Value: $41,250.00

Shares Owned: 58,832

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-04	Ruddy, Marcella K.	Officer	Chief Medical Officer	Direct	Sale	1,065	30.00	$31,950.00	67,682	4
2026-04-01	Ruddy, Marcella K.	Officer	Chief Medical Officer	Direct	Sale	1,000	31.05	$31,050.00	68,747	4
2026-03-06	Mcnamara, Peter	Officer	Chief Scientific Officer	Direct	Sale	6,262	32.50	$203,515.00	55,285	4
2026-03-06	Ruddy, Marcella K.	Officer	Chief Medical Officer	Direct	Sale	10,000	30.00	$300,000.00	69,747	4
2026-03-04	Mcnamara, Peter	Officer	Chief Scientific Officer	Direct	Sale	1,650	25.00	$41,250.00	58,832	4
2026-02-11	Reicin, Alise	Director,Officer	Chief Executive Officer	Indirect	Purchase	2,500	21.10	$52,750.00	127,030	4/A
2026-02-10	Lochner, Daniel	Officer	Chief Financial Officer	Direct	Purchase	6,000	21.61	$129,660.00	32,044	4
2025-04-09	Springer, Timothy A	Director,TenPercentOwner	-	Direct	Purchase	3,718	14.92	$55,472.56	4,317,276	4
2025-04-07	Mcguire, Terrance	Director	-	Indirect	Sale	500,000	17.10	$8,550,000.00	573,062	4
2025-04-07	Springer, Timothy A	Director,TenPercentOwner	-	Direct	Purchase	87,500	17.10	$1,496,250.00	4,313,558	4
2025-02-05	Lochner, Daniel	Officer	Chief Financial Officer	Direct	Purchase	4,617	54.14	$249,964.38	4,617	4
2025-02-05	Springer, Timothy A	Director,TenPercentOwner	-	Direct	Purchase	129,294	54.14	$6,999,977.16	4,226,058	4
2024-10-22	Springer, Timothy A	Director,TenPercentOwner	-	Direct	Purchase	300,000	33.59	$10,077,000.00	4,096,764	4
2024-09-26	Springer, Timothy A	Director,TenPercentOwner	-	Direct	Purchase	50,000	29.56	$1,478,000.00	3,796,764	4
2024-05-14	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	296,882	1.30	$385,946.60	4,768,262	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

70.69%

Inst. Shares: 13,267,867

Shares Outstanding: 18,769,004

2025-12-31

73.39%

Inst. Shares: 13,447,604

Shares Outstanding: 18,322,533

2025-09-30

63.06%

Inst. Shares: 11,800,815

Shares Outstanding: 18,712,767

2025-06-30

62.98%

Inst. Shares: 11,764,042

Shares Outstanding: 18,680,042

2025-03-31

62.35%

Inst. Shares: 10,698,014

Shares Outstanding: 17,157,661

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,267,867	18,769,004	70.69%
2025-12-31	13,447,604	18,322,533	73.39%
2025-09-30	11,800,815	18,712,767	63.06%
2025-06-30	11,764,042	18,680,042	62.98%
2025-03-31	10,698,014	17,157,661	62.35%
2024-12-31	7,665,383	8,490,171	90.29%
2024-09-30	7,164,451	14,729,018	48.64%
2024-06-30	5,199,691	2,919,872	178.08%
2024-03-31	27,332,616	1,387,303	-
2023-12-31	21,037,622	1,268,512	-
2023-09-30	23,358,075	1,319,147	-
2023-06-30	17,630,414	1,228,778	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Tectonic Therapeutic, Inc. (TECX) — SEC Financial Statements & Analysis

Tectonic Therapeutic, Inc. (TECX) is a biological products, (no diagnostic substances) company, incorporated in NY. Tectonic Therapeutic, Inc. trades on Nasdaq as: TECX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Tectonic Therapeutic, Inc. reported a Debt-to-Equity ratio of 0.06x, a Price-to-Book (P/B) ratio of 2.91x (TTM), at a market cap of $651.98M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.06x
P/B TTM: 2.91x
Market Cap: $651.98M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Tectonic Therapeutic, Inc. in?

Tectonic Therapeutic, Inc. (TECX) operates in the Biological Products, (No Diagnostic Substances) industry.

What is TECX's market cap?

Tectonic Therapeutic, Inc. (TECX) has a market capitalization of $651.98M as of 2026-06-30.

What exchange does TECX trade on?

Tectonic Therapeutic, Inc. (TECX) trades on the Nasdaq.

Where is Tectonic Therapeutic, Inc. incorporated?

Tectonic Therapeutic, Inc. is incorporated in NY.